Literature DB >> 7040765

Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro.

N Sidell.   

Abstract

Retinoic acid (RA) induced concentration-dependent morphologic differentiation and growth inhibition in the LA-N-1 human neuroblastoma cell line. Time course studies demonstrated a significant increase in the formation of long neurites in LA-N-1 cultures within 48 hours of RA addition; maximum expression of differentiation occurred at approximately 4 days. This differentiation profile corresponded to a detectable decrease in [3H]thymidine incorporation at 48 hours and complete inhibition of cell growth after 3-4 days. The RA-induced morphologic differentiation and growth inhibition persisted despite removal of the drug. A soft agar assay system showed that RA also inhibited the ability of LA-N-1 cells to form anchorage-independent colonies and induced morphologic differentiation in colonies that did develop. These findings suggest that RA promoted the differentiation of LA-N-1 neuroblastoma cells, resulting in an altered expression of the malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040765

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  97 in total

1.  Scanning electron microscopic evidence for neural differentiation in Ewing's sarcoma cell lines.

Authors:  S Navarro; M González-Devesa; A Ferrández-Izquierdo; T J Triche; A Llombart-Bosch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Histogenesis of the human adrenal medulla. An evaluation of the ontogeny of chromaffin and nonchromaffin lineages.

Authors:  M J Cooper; G M Hutchins; M A Israel
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

Review 3.  Nerve growth factor and neuronal cell death.

Authors:  J R Perez-Polo; P J Foreman; G R Jackson; D Shan; G Taglialatela; L W Thorpe; K Werrbach-Perez
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

4.  9-cis retinoic acid--a better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma.

Authors:  P E Lovat; H Irving; A J Malcolm; A D Pearson; C P Redfern
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

5.  Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.

Authors:  Svenja Nölting; Alessio Giubellino; Yasin Tayem; Karen Young; Michael Lauseker; Petra Bullova; Jan Schovanek; Miriam Anver; Stephanie Fliedner; Márta Korbonits; Burkhard Göke; George Vlotides; Ashley Grossman; Karel Pacak
Journal:  Endocrinology       Date:  2014-04-24       Impact factor: 4.736

Review 6.  The miR-10 microRNA precursor family.

Authors:  Disa Tehler; Nina Molin Høyland-Kroghsbo; Anders H Lund
Journal:  RNA Biol       Date:  2011-09-01       Impact factor: 4.652

7.  Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap.

Authors:  V Graham; E S Surwit; S Weiner; F L Meyskens
Journal:  West J Med       Date:  1986-08

8.  Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth.

Authors:  Erik H Knelson; Angela L Gaviglio; Jasmine C Nee; Mark D Starr; Andrew B Nixon; Stephen G Marcus; Gerard C Blobe
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

9.  A combined evaluation of biochemical and morphological changes during human neuroblastoma cell differentiation.

Authors:  M Lanciotti; P G Montaldo; S Folghera; E Lucarelli; P Cornaglia-Ferraris; M Ponzoni
Journal:  Cell Mol Neurobiol       Date:  1992-06       Impact factor: 5.046

10.  Retrospective analysis of peripheral blood stem cell transplantation for the treatment of high-risk neuroblastoma.

Authors:  Eun Kyung Kim; Hyoung Jin Kang; Jeong Ah Park; Hyoung Soo Choi; Hee Young Shin; Hyo Seop Ahn
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.